ClinicalTrials.gg
Not yet recruitingNCT07535853LPLT-TOSUpdated Apr 17, 2026

Effect of Low-Power Laser Therapy on Pain and Functional Outcomes in Patients With Thoracic Outlet Syndrome

An interventional study of Low level laser therapy and Therapeutic Ultrasound in Thoracic Outlet Syndrome, sponsored by Cairo University. Not yet recruiting. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-04-17.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effect of low-power laser therapy on pain intensity and functional outcomes in patients diagnosed with Thoracic Outlet Syndrome (TOS). Participants will be randomly assigned to either receive the active laser therapy combined with a physical therapy program or a control group. The study aims to determine if adding laser therapy provides better relief and improves daily physical functions compared to conventional treatment alone.

02

Conditions studied

  • Thoracic Outlet Syndrome

Keywords

  • LPLT
03

In context

Thoracic Outlet Syndrome

33 studies on the registry are indexed under Thoracic Outlet Syndrome; 11 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 17 interventional studies indexed under Thoracic Outlet Syndrome.

Browse Thoracic Outlet Syndrome studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Age

Inclusion Criteria:

  • Age between 35-50 years.
  • Clinically diagnosed with Thoracic Outlet Syndrome (TOS) by a physician based on standard diagnostic criteria.
  • Presence of neurogenic symptoms such as pain, paraesthesia, numbness, or --
  • weakness in the upper extremity.
  • Symptoms lasting for at least 3 months.

Exclusion Criteria:

  • History of cervical disc herniation or cervical radiculopathy.
  • Previous surgical intervention in the cervical or thoracic outlet region.
  • Severe cardiovascular or systemic diseases that may interfere with treatment. --Pacemakers or other implanted electronic devices.
  • Skin conditions or infections in the treatment area.
  • Receiving any other form of laser therapy or conflicting treatment during the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Participants will receive active laser therapy plus a standard physical therapy program (exercises a

    Participants will receive active laser therapy plus a standard physical therapy program (exercises and ultrasound)

    Device: Low level laser therapy · Device: Therapeutic Ultrasound · Behavioral: Physical Therapy Exercises

  • Sham comparator
    Control group have ultrasound and exercise and sham laser therapy

    Device: Therapeutic Ultrasound · Behavioral: Physical Therapy Exercises · Device: Sham Laser Therapy

Interventions

  • DeviceLow level laser therapy

    "Patients will receive low-level laser therapy using a Gallium-Aluminum-Arsenide (GaAlAs) laser diode. Wavelength: 850nm, Power: 100mW. It will be applied to specific trigger points in the neck and shoulder area for 5 minutes per session, 3 times per week for 4 weeks."

  • DeviceTherapeutic Ultrasound

    "Pulsed therapeutic ultrasound applied to the symptomatic area. Frequency: 1 MHz, Intensity: 1.5 W/cm², Duty cycle: 20%. The treatment will be applied for 5-8 minutes per session."

  • BehavioralPhysical Therapy Exercises

    A supervised physical therapy program focusing on stretching and strengthening exercises for the neck and shoulder girdle. This includes stretching of the scalene and pectoralis minor muscles, as well as strengthening of the middle and lower trapezius and serratus anterior. Each session lasts 30 minutes, twice per week for 8 weeks.

  • DeviceSham Laser Therapy

    "The same laser device will be used as in the experimental group, but without delivering any active laser energy. The device will be applied to the same points for the same duration to ensure blinding of the participants."

06

What researchers measure

Primary outcomes

  1. Pressure Pain Threshold (PPT)

    The minimum pressure at which a stimulus is perceived as painful, measured using a digital pressure algometer at specific trigger points. The device measures the pressure in kilograms per square centimeter (kg/cm²).

    Time frame: Baseline and 2 months post-treatment.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Jun 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2026
First posted
Apr 17, 2026
StartEst.
Apr 20, 2026
Primary completionEst.
Jun 20, 2026
CompletionEst.
Jul 17, 2026
Last update
Apr 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07535853
Lead sponsor
Cairo University
Responsible party
Eman Tarek Sayed Zakaria (Master's Student, Faculty of Physical Therapy, Cairo University) — Principal investigator
First posted
Apr 17, 2026
Start date
Apr 20, 2026 (estimated)
Primary completion
Jun 20, 2026 (estimated)
Completion
Jul 17, 2026 (estimated)
Last update
Apr 17, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion